5 completed, 1 unknown. 3 Phase 1, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Provention Bio, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Israeli Study for Islet Autoantibodies Screening in Families of Type-1 Diabetes Patients Type 1 Diabetes | Unknown | Rabin Medical Center | 300 | 2023-05-30 | 2024-03-27 | |
| PROtocol for Coxsackievirus VaccinE in Healthy VoluNTteers PRV-101, Placebo - Viral; Infection, Coxsackie(Virus) | Phase 1 | Completed | Provention Bio, Inc. | 32 | 2020-12-14 | 2022-07-25 |
| A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy Subjects PRV-3279 or placebo - Safety | Phase 1 | Completed | Provention Bio, Inc. | 16 | 2019-08-07 | 2023-08-28 |
| Recent-Onset Type 1 Diabetes Trial Evaluating Efficacy and Safety of Teplizumab teplizumab, Placebo - Type 1 Diabetes Mellitus | Phase 3 | Completed | Provention Bio, Inc. | 328 | 2019-04-05 | 2024-04-24 |
| Phase 2a Study of PRV-6527 in Subjects With Moderately to Severely Active Crohn's Disease PRV-6527, Placebo - Crohn's Disease | Phase 2 | Completed | Provention Bio, Inc. | 93 | 2018-03-20 | 2021-09-16 |
| A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis PRV-300, Placebo - Ulcerative Colitis | Phase 1 | Completed | Provention Bio, Inc. | 37 | 2018-02-21 | 2020-02-13 |
Diabetes Mellitus, Type 1 (2) · Colitis, Ulcerative (1) · Coxsackievirus Infections (1) · Crohn Disease (1) · Diabetes Mellitus (1)
teplizumab (1)
Germany (2) · Hungary (2) · Poland (2) · Ukraine (2) · United States (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Finland (1) · France (1) · Georgia (1) · Israel (1) · Moldova (1) · Russia (1)
PMID 37158990, PMID 37861217, PMID 38369573, PMID 39735417, PMID 42720752
2017 (1)